Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Nov 13 - Nov 18
32 Compared to GIP (142), GIP (130) has a symmetrical IC 50 , a slightly lower EC 50 , and a higher E max
Peptides can be delivered intranasally, subcutaneously, or orally depending on the compound, and starting with lower doses allows your body to adjust safely
The STEP 1 trial showed an average weight loss of 14.9% of body weight at this dose over 68 weeks
Methods Patients with a breast cancer diagnosis were prescribed GLP-1 RAs from January 1, 2015, to December 31, 2023, at Memorial Sloan Kettering Cancer Center in New York, New York, with follow-up weight data (before and during treatment with a GLP-1 RA) included in this retrospective cohort
The GLP-1 receptor agonists used in these trials included exenatide, liraglutide, NLY01 (a pegylated analogue of exenatide), and lixisenatide
US$ 24.27
US$ 22.30
US$ 25.97
US$ 20.06
US$ 27.60
US$ 20.63
US$ 28.14
US$ 20.01
US$ 26.00
